UVeyong Pharma uhambele kwa-22nd CPHI China 2024

Kusukela ngoJuni 19 kuya ku-21, i-22nd China China ne-17 Pmec China yabanjelwa eNew International Expo Centerin Shanghai. Li jianjie, umphathi ojwayelekile weUveléPharma, umxhasi we-Limin Pharmaceuticals, uDkt Li Linhu, iPhini Lomqondisi we-R & D Centrol Centre ye-Limin Pharmaceuticals, Dr. Fengqin Laboratorun, Umqondisi we-Labor, i-General FengoUveléPharma, noChen Lusheng, umqondisi woMnyango Wezokulawulwa Kwempahla, waya kulo mbukiso ngeqembu labo lokumaketha laphesheya.

EBooth E2A20,UveléI-Pharma ikhonjisiweIvermectin, abamectrin, tIamulin Fumarate, eprinomesctinneminye imikhiqizo ukuzeamakhasimendeemhlabeni jikelele. Imikhiqizo ehamba phambili yenkampani idlulise izitifiketi ze-US FDA kanye ne-EU CEP futhi yangena emakethe ephezulu kakhulu. Isakhiwo saso se-matrix esifanele, ikhwalithi yomkhiqizo ethembekile nezinhlobonhlobo zomkhiqizo ocebile ziye zamukelwa ngababukeli abaningi.

Isayithi lombukiso laligcwele abantu. Iqembu lezentengiso laphesheya belisenkingeni egcwele, linokushintshana okujulile nezivakashi eza ukuzobonisana, lalela izidingo zamakhasimende, futhi linikeze izimpendulo zobungcweti, libonisa amandla aphelele womkhiqizo kanye nenani lokubambisanaUveléEmakethe yomhlaba wonke, futhi kwasungulwa ukuxhumana okubanzi namakhasimende angaba khona esizeni.

Lo mbukiso usukhulisileUveléIziteshi zokuthengisa zikaTharma emakethe yamazwe omhlaba futhi zihlanganisa futhi idumela lenkampani nethonya emakethe ye-API yaphesheya. Esikhathini esizayo, inkampani izoqhubeka nokusheshisa ijubane lokuthuthukiswa kwamamakethe aphesheya kanye nokuthuthuka okuqhubekayoUveléIthonya lomkhiqizo we-Pharma kanye nokuncintisana kwemakethe emkhakheni we-APIkanye namalungiselelo.